Immunohematopoietic stem cell transplantation: Introduction and 35 years of development in South Africa - The historical and scientific perspective

Bone Marrow Transplantation

Volumn 42, Issue SUPPL.1, 2008, Pages

  Jacobs, P ^a,b   Wood, L ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYCLOSPORIN A; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE;

ACCREDITATION; ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC GRAFT VERSUS HOST DISEASE; CLONOGENIC ASSAY; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; CYTOMEGALOVIRUS INFECTION; DRUG COST; FANCONI ANEMIA; FLOW CYTOMETRY; FREEZING; GRANULOCYTE TRANSFUSION; HEALTH CARE COST; HEALTH PROGRAM; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY OF MEDICINE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTERDISCIPLINARY COMMUNICATION; LYMPHATIC LEUKEMIA; MEDICAL AUDIT; NONHUMAN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; REGISTER; REVIEW; SOUTH AFRICA; STEM CELL MOBILIZATION; T CELL DEPLETION; WHOLE BODY RADIATION;

GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SOUTH AFRICA;

EID: 50549083355     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.140     Document Type: Review

References (35)

1. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE et al. Bone-marrow transplantation (first of two parts). N Engl J Med 1975; 292: 832-843.
2. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895-902.
3. Forman SJ. Planning and management for related and unrelated donor transplantation: Day 10 to day 100. Blood Marrow Transplant Rev 2007; 17: 5-7.
4. Wingard J. Current strategies and future concepts for prophylactic therapy. Blood Marrow Transplant Rev 2007; 17: 5-8.
5. Loberiza Jr FR, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS et al. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood 2005; 105: 2979-2987.
6. Loberiza Jr FR, Serna DS, Horowitz MM, Rizzo JD. Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: What do we know? Bone Marrow Transplant 2003; 31: 417-421.
7. Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG et al. Morbidity and mortality with nonmyelo-ablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 2004; 104: 1550-1558.
8. Claessens JJ, Beerendonk CC, Schattenberg AV. Quality of life, reproduction and sexuality after stem cell transplantation with partially T-cell-depleted grafts and after conditioning with a regimen including total body irradiation. Bone Marrow Transplant 2006; 37: 831-836.
9. Cilley J, Winter JN. Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas. Haematologica 2006; 91: 114-120.
10. Jacobs P, Wood L, Fullard L, Waldmann H, Hale G. T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease. Bone Marrow Transplant 1994; 13: 763-769.
11. Elliott MA, Tefferi A, Hogan WJ, Letendre L, Gastineau DA, Ansell SM et al. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia. Bone Marrow Transplant 2006; 37: 1003-1008.
12. Hogan WJ, Little MT, Zellmer E, Friedetzky A, Diaconescu R, Gisburne S et al. Postgraftihg immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biol Blood Marrow Transplant 2003; 9: 489-495.
13. Standards for haematopoietic progenitor cell collection, processing and transplantation. The Joint Accreditation Committee of ISCT-EBMT, 2nd edn. 2005. http://www.jacie.org.
14. European Federation for Immunogenetics. http://www.efiweb.org.
15. Lee S. Routine long-term follow-up of hematopoietic cell transplantation survivors. Blood Marrow Transplant Rev 2007; 17: 9-10.
16. Jacobs P, Wood L. Immunohaematopoietic stem cell transplantation in South Africa: The first 40 years - an experimental and clinical model for approaching restorative medicine. Specialist Forum 2006; 6 34-43.
17. Chandy M, Srivastava A, Dennison D, Mathews V, George B. Allogeneic bone marrow transplantation in the developing. world: Experience from a center in India. Bone Marrow Transplant 2001; 27: 785-790.
18. Creemers P, Jacobs P, Bird A, Du Toit E. The South African Bone Marrow Donor Registry. S Afr Med J 1993; 83: 819-821.
19. Fouillard L, Labopin M, Gratwohl A, Powles R, Bacigalupo A, Bego G et al. Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: A reliability study of the registry. Bone Marrow Transplant 2001; 30: 813-831.
20. Wood L, Hester JP, Jacobs P. Apheresis - from theory to practice. CME 1993; 11: 1127-1134.
21. Jacobs P. Effect of cyclosporin A on the incidence of graft-versus-host disease (GVHD) and survival of rabbits following allogeneic bone marrow transplantation. In: Baum SJ, Ledney GD, Khan A (eds). Experimental Hematology Today 1981. Karger: Basel, 1981, pp 87-96.
22. Jacobs P, Eglin L. Cyclosporin A. Current status, including the Cape Town experience. In: Fenichel RL, Chirigos MA (eds). Immune Modulation Agents and their Mechanisms. Marcel Dekker Inc.: New York, 1984, pp 191-228.
23. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trial in Chronic Graft-versus-Host Disease. I. Diagnosis and Staging Working Group. Biol Blood Marrow Transplant 2005; 11: 945-955.
24. Chao NJ, Chen BJ. Prophylaxis and treatment of acute graft-versus-host disease. Semin Hematol 2006; 43: 32-41.
25. Jacobs P, Bareford D, Parker JR, Milns B, Manuel G. An evaluation of cyclosporin A in reducing the incidence of graft-versus-host disease in rabbits undergoing allogeneic bone marrow transplantation. Sandoz- Medical Bulletin 1980; 9: 32-35.
26. Funke VAM, de Medeiros CR, Setubal DC, Ruiz J, Bitencourt MA, Bonfim CM et al. Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist. Bone Marrow Transplant 2006; 37: 961-965.
27. Barge RM, Starrenburg CW, falkenburg JH, Fibbe WE, Marijy EW, Willemze R. Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath 'in the bag' as T-cell depletion: The Leiden experience. Bone Marrow Transplant 2006; 37: 1129-1134.
28. Barendse G, Tailford R, Wood L, Jacobs P. The effect of peptide stimulation on haematopoietic stem cell mobilization including engraftment characteristics and a note on donor side effects. Transfus Apheresis Sci 2005; 32: 105-116.
29. Jacobs P, Wood L. Bone marrow transplantation in the private sector. S Afr Med J 2000; 90: 321-322.
30. Wood L, Jacobs P. Bone marrow transplanlation. Department of Haematology and Bone Marrow Transplantation Unit. Constantiaberg Medi-Clinic: Plumstead, 2002.
31. Jacobs P, Wood L, Borrill V, Schlaphoff T, du Toit ED. Unrelated bone marrow transplantation in South Africa: A single centre experience. 5th South African Haematopoietic Stem Cell Transplantation Symposium, Cape Town, 2-3 March 2007.
32. Wood L, Juritz J, Havemann J, Lund J, Waldmann H, Hale G, Jacobs P. Paediatric immunohaematopoietic stem cell transplantation in Cape Town: a private academic centre programme (in press).
33. Jacobs P, Wood L, Haveman J, Juritz J. Adult immunohaematopoietic stem cell transplantation in Cape Town: A private academic centre ten year experience (Forthcoming).
34. Wood L, Robinson R, Gavine L, Juritz J, Jacobs P. Single unit lymphoma experience: Outcome in a Cape Town academic centre. Transfus Apher Sci 2007; 37: 93-102.
35. Wood L, Armitage JO, Diehl V, Fuchs M, Jacobs P. Transplantation in the lymphomas. Specialist Forum 2007; 7: 22-33.